Quick answer: No. Methocarbamol, a non-controlled muscle relaxant, is not one of the drug classes on a standard 10-panel urine drug test, and it is not known to trigger a positive on any of them. It would only be found with a specialized lab method, such as an expanded LC-MS/MS panel, that targets it specifically.
- A standard 10-panel cup or dip card does not include methocarbamol as a target analyte.
- A donor taking it should not produce a non-negative result on the panel because of it, but confirm against your specific device's package insert.
- Unexpected non-negative results go to laboratory confirmation, not straight to an adverse decision.
What a 10-panel test actually detects
A 10-panel urine test screens for ten drug classes. The exact mix varies by manufacturer and by what your program requires. A commonly used configuration includes:
Need drug tests for your clinic, program or workplace?
American Screening Corp has supplied FDA-cleared, CLIA-waived tests at wholesale pricing since 2004. Popular options:
- 10-panel drug test cups and dip cards
- 12-panel drug test cups
- all drug test cups (wholesale pricing)
Ordering 100+ tests? Request volume pricing.
- Amphetamines / methamphetamine
- Cocaine (benzoylecgonine metabolite)
- Marijuana (THC metabolite)
- Opiates
- Phencyclidine (PCP)
- Barbiturates
- Benzodiazepines
- Methadone
- Oxycodone or MDMA, depending on the configuration
- Methaqualone or propoxyphene on some older configurations
Methocarbamol is not in any of these classes. It is a centrally acting skeletal muscle relaxant, not an opioid, benzodiazepine or barbiturate. NIH MedlinePlus describes it as a muscle relaxant used with rest and physical therapy for acute musculoskeletal conditions.
Cutoff levels you will see on devices
Cutoffs are set by the device manufacturer and your policy, so always read the insert. Typical immunoassay screening cutoffs in urine are often in ranges like these:
| Drug class | Common screening cutoff (ng/mL) | Methocarbamol effect |
|---|---|---|
| Amphetamines | 500 to 1,000 | Not a target |
| Cocaine metabolite | 150 to 300 | Not a target |
| THC metabolite | 50 | Not a target |
| Opiates | 300 to 2,000 | Not a target |
| PCP | 25 | Not a target |
| Barbiturates | 200 to 300 | Not a target |
| Benzodiazepines | 200 to 300 | Not a target |
| Methadone | 300 | Not a target |
These ranges are illustrative, not a specification for any one product. Confirm the cutoff printed on the lot you are using.
Why a screening result could still surprise you
Immunoassay screens use antibodies that can occasionally cross-react with unrelated compounds. Methocarbamol is not a commonly cited cross-reactant on the standard panels, but no screen is perfect, and the package insert for your device is the authority on known interferences. That is why a screen is treated as preliminary.
The more common source of confusion is a donor who takes several medications at once. A muscle relaxant is often prescribed alongside an opioid or a benzodiazepine, and those do appear on the panel. A non-negative result is far more likely to reflect one of those drugs than methocarbamol.
How to read and act on results
- Check the control line first. A missing control line means the test is invalid; retest with a new device.
- Read the result window within the time stated in the insert. Do not read after the window closes.
- Treat any visible test line, however faint, as negative for that drug on a standard line-based device, per the insert.
- Treat a missing line in a drug column as a non-negative (presumptive positive) screen.
- Send non-negative specimens, with chain of custody, to a laboratory for confirmation.
- Give the donor a chance to explain prescriptions before any decision, following your policy and applicable law.
When methocarbamol testing is needed
Some pain-management, addiction-treatment and probation programs want to verify that a patient or client is taking, or not taking, a prescribed muscle relaxant. A standard cup cannot do this. A laboratory can add methocarbamol to an expanded or definitive panel using chromatography with mass spectrometry. Ask your lab which compounds it reports and at what reporting limit.
Decision guide
- Goal is pre-employment or random screening for common drugs: a standard 10-panel is appropriate.
- Goal is medication-adherence monitoring: use a lab-based expanded panel.
- Goal is a regulated DOT test: follow the federal 49 CFR Part 40 panel and procedures, which are separate from a commercial 10-panel.
Buyer checklist for clinics, employers and courts
- Confirm the exact analytes and cutoffs on the product insert.
- Verify the device's FDA clearance and CLIA-waived status for the product you intend to buy.
- Choose a format that fits your volume: drug test cups for integrated collection and temperature strips, or drug test dip cards for a lower-cost, flexible format.
- Write a policy for prescription disclosure and a medical review step.
- Arrange lab confirmation before you need it.
- Train staff on reading windows, invalid results and chain of custody.
- Keep lot numbers and expiration dates in your records.
Policy and compliance notes
For federally regulated workplace testing, the Department of Transportation and SAMHSA set the drug panel and procedures. Those programs test a defined list of drugs, and methocarbamol is not on it. Non-regulated employers have more latitude, but state law, union agreements and company policy can limit what you test and how you act on results. Review your program with counsel.
If your screening program is part of a larger hiring process, pair it with employment screening through Reveal Background, our sister division, so that testing and background checks run on a consistent schedule.
Frequently asked questions
Does methocarbamol show up on a standard 10-panel urine test?
No. It is not a target analyte on standard 10-panel screens and is not a controlled substance class those tests cover. Only a lab method that specifically targets it would detect it.
Can methocarbamol cause a false positive?
It is not a commonly reported cross-reactant on standard panels, but every immunoassay has limits. Check the device insert and send any non-negative screen for laboratory confirmation.
Is methocarbamol on the DOT or SAMHSA panel?
No. Federal workplace testing covers a defined list of drugs, and methocarbamol is not among them.
How can a program test for methocarbamol specifically?
Ask a laboratory for an expanded or definitive panel that includes it, typically run by LC-MS/MS. Confirm the reporting limit and specimen requirements before ordering.
Sources
- NIH MedlinePlus: Methocarbamol
- U.S. Department of Transportation: Office of Drug and Alcohol Policy and Compliance
- SAMHSA: Workplace Drug Testing
Questions about matching a panel to your program? Contact American Screening Corp.
This article is general information, not legal or medical advice.
